{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:55:30Z","timestamp":1791028530121,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.drudis.2007.10.024","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T12:16:12Z","timestamp":1203682572000},"page":"234-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases"],"prefix":"10.1016","volume":"13","author":[{"given":"Gareth J.","family":"Sanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2007.10.024_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0196-9781(96)00333-6","article-title":"Motilin and clinical application","volume":"18","author":"Itoh","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.drudis.2007.10.024_bib2","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1126\/science.284.5423.2184","article-title":"Receptor for motilin identified in the human gastrointestinal system","volume":"284","author":"Feighner","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.drudis.2007.10.024_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2982.1999.00147.x","article-title":"The patterns of small bowel motility: physiology and implications in organic disease and functional disorders","volume":"11","author":"Husebye","year":"1999","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.drudis.2007.10.024_bib4","series-title":"Problems of the Gastrointestinal Tract in Anaesthesia","first-page":"39","article-title":"Potential of motilides in the treatment of hypomotility syndromes","author":"Peeters","year":"1999"},{"key":"10.1016\/j.drudis.2007.10.024_bib5","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/en.2005-1357","article-title":"Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor","volume":"147","author":"Toshinai","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2007.10.024_bib6","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/eje.0.144r001","article-title":"Ghrelin and motilin: two sides of one coin?","volume":"144","author":"Folwaczny","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.drudis.2007.10.024_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.coph.2006.08.005","article-title":"Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders","volume":"6","author":"Peeters","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.drudis.2007.10.024_bib8","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/sj.bjp.0705505","article-title":"The rabbit motilin receptor: molecular characterisation and pharmacology","volume":"140","author":"Dass","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2007.10.024_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2005.08.062","article-title":"Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin","volume":"392","author":"Rudd","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drudis.2007.10.024_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2005.09.007","article-title":"Prokineticin-2, motilin, ghrelin and metoclopramide: prokinetic utility in mouse stomach and colon","volume":"524","author":"Bassil","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2007.10.024_bib11","first-page":"A54","article-title":"Molecular, functional and cross-species comparisons between the receptors for the prokinetic neuropeptides, motilin and ghrelin","volume":"122","author":"Hill","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2007.10.024_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.peptides.2006.11.011","article-title":"Motilin activates neurons in the rat amygdale and increases gastric motility","volume":"28","author":"Feng","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.drudis.2007.10.024_bib13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1124\/jpet.104.081497","article-title":"Desensitization of the human motilin receptor by motilides","volume":"313","author":"Thielemans","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2007.10.024_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00535-005-1739-0","article-title":"Molecular characterisation and distribution of motilin family receptors in the human gastrointestinal tract","volume":"41","author":"Takeshita","year":"2006","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.drudis.2007.10.024_bib15","first-page":"G224","article-title":"Motilin is a biosignal controlling cyclic release of pancreatic polypeptide via the vagus in fasted dogs","volume":"272","author":"Mochiki","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.drudis.2007.10.024_bib16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/jpet.102.047563","article-title":"Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum","volume":"305","author":"Depoortere","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2007.10.024_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bjp.0707118","article-title":"Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro","volume":"150","author":"Jarvie","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2007.10.024_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1046\/j.1365-2036.1997.00177.x","article-title":"Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus","volume":"11","author":"Annese","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2007.10.024_bib19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1159\/000007687","article-title":"Prokinetics in patients with gastroparesis: a systematic analysis","volume":"60","author":"Sturm","year":"1999","journal-title":"Digestion"},{"key":"10.1016\/j.drudis.2007.10.024_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/gut.43.3.395","article-title":"Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans","volume":"43","author":"Coulie","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2007.10.024_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1572-0241.2005.00339.x","article-title":"Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways","volume":"101","author":"Cuomo","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.drudis.2007.10.024_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1592\/phco.23.1.5.31919","article-title":"Erythromycin accelerates gastric emptying in a dose-response manner in healthy subjects","volume":"23","author":"Boivin","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drudis.2007.10.024_bib23","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00134-005-2663-8","article-title":"Erythromycin dose of 70mg accelerates gastric emptying as effectively as 200mg in the critically ill","volume":"31","author":"Ritz","year":"2005","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.drudis.2007.10.024_bib24","first-page":"203","article-title":"The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin","volume":"88","author":"Richards","year":"1993","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.drudis.2007.10.024_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00004836-200403000-00008","article-title":"Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis","volume":"38","author":"Dhir","year":"2004","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.drudis.2007.10.024_bib26","first-page":"103","article-title":"Distribution and subcellular localization of motilin binding sites in the rabbit brain","volume":"777","author":"Depoortere","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2007.10.024_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-4684-7248-6_35","article-title":"Motilin-, substance P- and somatostatin-like immunoreactivities in extracts from dog, tupaia and monkey brain and GI tract","volume":"106","author":"Yanaihara","year":"1978","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.drudis.2007.10.024_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00004836-199903000-00009","article-title":"Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one centre's experience","volume":"28","author":"Dibaise","year":"1999","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.drudis.2007.10.024_bib29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/gut.2005.078121","article-title":"Treatment options for patients with severe gastroparesis","volume":"56","author":"Abrahamsson","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2007.10.024_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jac\/dkl537","article-title":"The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks","volume":"59","author":"Hawkyard","year":"2007","journal-title":"J. Antimicrobial. Chemother."},{"key":"10.1016\/j.drudis.2007.10.024_bib31","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1365-2036.2000.00868.x","article-title":"Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial","volume":"14","author":"Talley","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2007.10.024_bib32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/gut.49.3.395","article-title":"Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial","volume":"49","author":"Talley","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2007.10.024_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2362.1999.00364.x","article-title":"The effects of ABT-229 and octreotide on interdigestive small bowel motility, bacterial overgrowth and bacterial translocation in rats","volume":"29","author":"Nieuwenhuijs","year":"1999","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.drudis.2007.10.024_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/gut.49.3.317","article-title":"What comes after macrolides and other motilin stimulants?","volume":"49","author":"Tack","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2007.10.024_bib35","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1016\/j.bmcl.2007.05.043","article-title":"Potent macrocyclic antagonists to the motilin receptor presenting novel unnatural amino acids","volume":"17","author":"Marsault","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2007.10.024_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.drudis.2007.02.009","article-title":"Physiological, pathophysiological and potential therapeutic roles of ghrelin","volume":"12","author":"Leite-Moreira","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2007.10.024_bib37","first-page":"G1376","article-title":"Ghrelin selectively reduces mechanosensitivity of upper gastrointestinal vagal afferents","volume":"292","author":"Page","year":"2007","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.drudis.2007.10.024_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4522(03)00327-0","article-title":"Growth hormone secretagogue receptors in the rat and human gastrointestinal tract and the effects of ghrelin","volume":"120","author":"Dass","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.drudis.2007.10.024_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.regpep.2004.04.001","article-title":"Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons","volume":"121","author":"Edholm","year":"2004","journal-title":"Reg. Peptides"},{"key":"10.1016\/j.drudis.2007.10.024_bib40","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1210\/jc.2004-2537","article-title":"Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy","volume":"90","author":"le Roux","year":"2005","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.drudis.2007.10.024_bib41","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/jpet.102.034827","article-title":"Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure","volume":"302","author":"Banks","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2007.10.024_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.regpep.2004.02.010","article-title":"Exogenous and endogenous ghrelin in gastroprotection against stress-induced damage","volume":"120","author":"Brzozowski","year":"2004","journal-title":"Reg. Peptides"},{"key":"10.1016\/j.drudis.2007.10.024_bib43","first-page":"774","article-title":"Increased plasma ghrelin level in lung cancer cachexia","volume":"9","author":"Shimizu","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drudis.2007.10.024_bib44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0196-9781(03)00113-X","article-title":"Two new peptides to improve post-operative gastric ileus in dog","volume":"24","author":"Trudel","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.drudis.2007.10.024_bib45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2982.2004.00564.x","article-title":"Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice","volume":"16","author":"De Winter","year":"2004","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.drudis.2007.10.024_bib46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00280-005-0179-0","article-title":"Ghrelin alleviates cancer chemotherapy-associated dyspepsia in mice","volume":"58","author":"Liu","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.drudis.2007.10.024_bib47","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2003-031768","article-title":"Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial","volume":"89","author":"Neary","year":"2004","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.drudis.2007.10.024_bib48","first-page":"E1829","article-title":"Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects","volume":"292","author":"Vestergaard","year":"2007","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.drudis.2007.10.024_bib49","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1117255","article-title":"Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake","volume":"310","author":"Zhang","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.drudis.2007.10.024_bib50","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1126\/science.1137136","article-title":"Response to comment on Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake","volume":"315","author":"Zhang","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.drudis.2007.10.024_bib51","first-page":"R637","article-title":"Obestatin acts in brain to inhibit thirst","volume":"292","author":"Samson","year":"2007","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.drudis.2007.10.024_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/sj.bjp.0706969","article-title":"Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract","volume":"150","author":"Bassil","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2007.10.024_bib53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2982.2006.00883.x","article-title":"Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents","volume":"19","author":"De Smet","year":"2007","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.drudis.2007.10.024_bib54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1677\/joe.1.06944","article-title":"Distribution and biological activity of obestatin in the rat","volume":"191","author":"Dun","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.drudis.2007.10.024_bib55","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.gastro.2006.07.009","article-title":"Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse","volume":"131","author":"Moechars","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2007.10.024_bib56","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/me.2007-0055","article-title":"GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver and white adipose tissue","volume":"21","author":"Egerod","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.drudis.2007.10.024_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-5793(98)01056-4","article-title":"Isolation and sequence of cDNA encoding the motilin precursor from monkey intestine. Demonstration of the motilin precursor in the monkey brain","volume":"435","author":"Huang","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drudis.2007.10.024_bib58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.2007.03346.x","article-title":"Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial","volume":"26","author":"McCallum","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2007.10.024_bib59","doi-asserted-by":"crossref","unstructured":"Peeters, T.L. (2006) New motilin agonists: a long and winding road","DOI":"10.1111\/j.1365-2982.2005.00749.x"},{"key":"10.1016\/j.drudis.2007.10.024_bib60","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1023\/A:1022528414264","article-title":"Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients","volume":"48","author":"Gonlachanvit","year":"2003","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.drudis.2007.10.024_bib61","first-page":"259","article-title":"Oral erythromycin and symptomatic relief of gastroparesis: a systematic review","volume":"98","author":"Maganti","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.drudis.2007.10.024_bib62","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1572-0241.2006.00582.x","article-title":"Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial","volume":"101","author":"Carbonell","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.drudis.2007.10.024_bib63","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1378\/chest.125.2.587","article-title":"Transpyloric feeding tube placement in critically ill patients using electromyogram and erythromycin infusion","volume":"125","author":"Levy","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.drudis.2007.10.024_bib64","unstructured":"Madsen, J.L. et al. (2007) Ghrelin agonist (TZP-101) gastroprokinetic action in diabetic patients with gastroparesis: a pilot study. American Diabetes Association (Abstract 599-P)"},{"key":"10.1016\/j.drudis.2007.10.024_bib65","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s10620-007-9783-7","article-title":"Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus","volume":"52","author":"Venkovak","year":"2007","journal-title":"Dig. Dis. Sci."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644607004679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644607004679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:02:05Z","timestamp":1761220925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644607004679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":65,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1359644607004679"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2007.10.024","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2007.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}